GLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ GenesGLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ Genes
SLU-PP-332 100mg x30 Capsules
Exercise Mimetic

SLU-PP-332 100mg x30 Capsules

SLU-PP-332

CAS: 2413942-14-8

$53.99$59.9910% OFFIn Stock

SLU-PP-332 is a first-in-class pan-ERR (estrogen-related receptor) agonist that activates ERRa, ERRb, and ERRg — the master transcriptional regulators of mitochondrial biogenesis and oxidative metabolism. Animal studies show endurance enhancement, fat oxidation, and cardiac protection without exercise. 99.0% HPLC purity.

Specifications

Count30 capsules
Per capsule100mg
FormOral capsule
Purity99.0% HPLC
StorageCool, dry place
Shop This Compound

For laboratory research use only. Not for human consumption.

Mechanism of Action

Pan-ERR agonism drives PGC-1a coactivation, upregulating mitochondrial biogenesis genes, fatty acid oxidation enzymes, and oxidative phosphorylation complexes. Unlike AICAR (AMPK-mediated), SLU-PP-332 acts directly on ERR nuclear receptors, producing a transcriptional exercise-adaptation signature.

Research FAQ

How does SLU-PP-332 differ from AICAR?

AICAR activates AMPK indirectly via ZMP. SLU-PP-332 directly agonizes ERR nuclear receptors, producing a broader transcriptional exercise-adaptation response including cardiac and skeletal muscle mitochondrial biogenesis with stronger ERRg activity.

Related Compounds